Financial Statements — INBX
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Cash & Equivalents | 133.34 | 161.66 | 153.09 | 186.57 | 216.52 | 196.33 | 226.86 |
| Total Current Assets | 142.21 | 171.34 | 161.42 | 193.96 | 223.39 | 207.45 | 242.06 |
| Property, Plant & Equipment | 2.69 | 3.20 | 4.31 | 4.89 | 5.55 | 6.88 | 7.61 |
| Total Non-current Assets* | 12.01 | 12.63 | 16.05 | 18.15 | 19.25 | 15.12 | 16.36 |
| Total Assets | 154.22 | 183.97 | 177.47 | 212.12 | 242.64 | 222.56 | 258.42 |
| Accounts Payable | 9.80 | 8.76 | 6.77 | 8.29 | 8.89 | 12.37 | 13.02 |
| Total Current Liabilities | 28.06 | 26.51 | 35.98 | 38.94 | 43.64 | 44.10 | 39.05 |
| Long-term Debt | 176.29 | 174.99 | 99.92 | 99.28 | 98.65 | 0.00 | 0.00 |
| Total Non-current Liabilities* | 179.14 | 178.49 | 104.66 | 104.62 | 104.56 | 0.00 | 0.00 |
| Total Liabilities | 207.20 | 205.00 | 140.64 | 143.56 | 148.20 | 44.10 | 39.05 |
| Retained Earnings | (316.28) | (279.63) | (213.35) | (178.10) | (149.44) | (58.27) | (14.40) |
| Total Stockholder Equity | (52.98) | (21.03) | 36.83 | 68.56 | 94.44 | 178.47 | 219.37 |
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Total Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Research & Development | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | 0.04 | 0.07 |
| Selling, General & Admin | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.09 |
| Total Operating Expenses | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.05 | 0.16 |
| Operating Income | (0.03) | (0.03) | (0.03) | (0.03) | (0.03) | (0.04) | (0.05) | (0.05) | (0.16) |
| Pretax Income | (0.04) | (0.03) | (0.03) | (0.04) | (0.03) | (0.04) | -- | (0.04) | 1.86 |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (0.04) | (0.03) | (0.03) | (0.04) | (0.03) | (0.04) | (0.05) | (0.04) | 1.86 |
| Basic EPS | (2.34) | (2.15) | (2.11) | (2.28) | (1.85) | (2.80) | (5.03) | (2.84) | 127.10 |
| Diluted EPS | (2.34) | (2.15) | (2.11) | (2.28) | (1.85) | (2.80) | (4.47) | (2.84) | 125.48 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Operating Cash Flow | (29.92) | (38.03) | (30.12) | (33.82) | (29.95) | (35.90) | (43.72) | (30.28) | (120.41) |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 | 0.02 | 0.25 | 2.33 |
| Free Cash Flow* | (29.92) | (38.03) | (30.12) | (33.83) | (29.95) | (35.92) | (43.74) | (30.53) | (122.74) |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 | (0.02) | (0.02) | (0.25) | (2.33) |
| Financing Cash Flow | 1.60 | 75.46 | 1.25 | 0.35 | 0.00 | 99.84 | 0.00 | 0.00 | 71.68 |
* Derived from reported values
